Sessions
Parallel Program
THURSDAY, MAY 23
13:30-14:00 Registration
14:00-14:10 Welcome address: James Yang (National Taiwan University Cancer Center, Taiwan)
Welcome address: Pai-Chi Li (National Taiwan University, Taiwan)
Parallel Session 1
Moderator: Chien-Yu Chen (National Taiwan University, Taiwan)
14:10-14:35 Suzuki Yutakai (The University of Tokyo, Japan)
‘Spatial Analysis for Elucidating Cancer Micro-environments’ (Video Presentations)
14:35-15:00 T. Tony Yang (National Taiwan University, Taiwan)
‘Spatial Analysis for Elucidating Cancer Micro-environments’
15:10-15:25 Yuan-Chung Cheng (National Taiwan University, Taiwan)
‘Elucidating Dynamics of Light Harvesting in Natural Photosynthesis: from Multiscale Molecular Simulation to Quantum Computing’
Parallel Session 2
Moderator: Hsueh-Fen Juan (National Taiwan University, Taiwan)
15:25-15:50 Akihiro Funamizu (The University of Tokyo, Japan)
‘Artificial Neural Network for modeling mouse decision making’
15:50-16:15 Hsueh-Fen Juan (National Taiwan University, Taiwan)
‘Advancing Drug Discovery: Targeting Metabolic Pathways in
Cancer Therapy’
16:15-16:40 Kevin T. Chen (National Taiwan University, Taiwan)
‘MR-Styled PET: Dual-modality Fusion for PET Image Enhancement’
FRIDAY, MAY 24
09:10-09:30 MOU Signing Ceremony
Special Keynote
09:30-10:10 Katsuhiko Shirahige (The University of Tokyo, Japan)
‘Basic principles of transcription studied through rare diseases’
10:10-10:35 Yuki Okada (The University of Tokyo, Japan)
‘Isolation of Stage-Specific Spermatogenic Cells Using Histone Exchange and Application to Sperm Chromatin Dynamics Analysis’
10:35-11:00 Break
Parallel Session 3
Moderator: Jian-Da Lin (National Taiwan University, Taiwan)
11:00-11:25 Ryuichiro Nakato (The University of Tokyo, Japan)
‘Computational pipelines for integrative analysis of multi-omics data’
11:25-11:50 Jian-Da Lin (National Taiwan University, Taiwan)
‘Revolutionize the Technologies for Single-Cell Multi-Omics Analysis’
11:50-12:15 Che Lin (National Taiwan University, Taiwan)
‘From Data to Discovery: The Impact of Large Language Models on Drug Target Affinity Prediction’
12:15- Closing